Physician profile
Peggy Wallace
NPI 1841862059
$1,195.55
in general payments reported to CMS, 2019-2025
13 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $210 · 2024: $419 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $312.38 | 2023-2025 | |
| Solventum Corporation | $243.22 | 2024-2025 | Prevena, Activ.A.C., Promogran Prisma |
| Mimedx Group, INC. | $181.15 | 2024-2025 | |
| Urgo Medical North America, LLC | $72.52 | 2022 | |
| Molnlycke Health Care US, LLC | $71.96 | 2023 | Mepilex Border Sacrum, Mepilex, Mlnlyckez-Flo Fluidized Positioner |
| Kerecis Limited | $64.67 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tactile Systems Technology INC | $56.30 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kci USA, INC. | $51.75 | 2023 | Activ.A.C., V.A.C. Dermatac, 3m Coban |
| Janssen Pharmaceuticals, INC | $40.83 | 2022 | |
| Next Science LLC | $35.65 | 2023 | Surgx, Xperience, Blastx |
| Nevro Corp. | $33.08 | 2022 | |
| Abbvie INC. | $18.91 | 2023 | |
| Medtronic, INC. | $13.13 | 2024 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.